» Articles » PMID: 20922712

Pin1 Acts As a Modulator of Cell Proliferation Through Alteration in NF-κB but Not β-catenin/TCF4 Signalling in a Subset of Endometrial Carcinoma Cells

Overview
Journal J Pathol
Specialty Pathology
Date 2010 Oct 6
PMID 20922712
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Prolyl isomerase Pin1 is frequently up-regulated in a variety of human malignancies, modulating signalling in several oncogenic pathways, including those involving NF-κB and β-catenin. Our previous study provided evidence that alterations in these signal pathways are essential events during trans-differentiation of endometrial carcinoma (Em Ca) cells. Here we focused on the functional roles of Pin1. In normal endometrium, Pin1 expression showed a stepwise decrease from proliferative to secretory phases during the menstrual cycle, correlating positively with cell proliferation and expression of several cell cycle-related molecules including E2F1 and pRb. Transfection of E2F1 caused transactivation of Pin1, indicating control by E2F1/Rb pathways. In Em Cas with morules, Pin1 expression was found to be significantly increased in glandular but not in morular components, correlating inversely with nuclear accumulation of β-catenin. Overexpression also caused an increase in the stability of nuclear p65, leading to enhancement of NF-κB-mediated transactivation of the cyclin D1 gene, in contrast to minimal inhibition of β-catenin/TCF4 transcription activity. These findings indicate that Pin1 may play an important role in preserving cell proliferative activity in glandular carcinoma components through enhancement of NF-κB signalling, but its down-regulation may be a key signal for induction of trans-differentiation of Em Ca cells, contributing to a shift from NF-κB to β-catenin/TCF signalling pathways.

Citing Articles

PIN1P1 is activated by CREB1 and promotes gastric cancer progression via interacting with YBX1 and upregulating PIN1.

Wang Y, Zhu W, Ma R, Tian Y, Chen X, Gao P J Cell Mol Med. 2023; 28(1):e18022.

PMID: 37929660 PMC: 10805483. DOI: 10.1111/jcmm.18022.


Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.

Chuang H, Zhen Y, Tsai Y, Chuang C, Huang M, Hsiao M Biomedicines. 2021; 9(4).

PMID: 33807199 PMC: 8065645. DOI: 10.3390/biomedicines9040359.


Isoquinolinequinone Derivatives from a Marine Sponge ( sp.) Regulate Inflammation in In Vitro System of Intestine.

Kim Y, Ji Y, Kim N, Van Tu N, Rho J, Jeong E Mar Drugs. 2021; 19(2).

PMID: 33557170 PMC: 7913985. DOI: 10.3390/md19020090.


Pin1 promotes pancreatic cancer progression and metastasis by activation of NF-κB-IL-18 feedback loop.

Sun Q, Fan G, Zhuo Q, Dai W, Ye Z, Ji S Cell Prolif. 2020; 53(5):e12816.

PMID: 32347623 PMC: 7260075. DOI: 10.1111/cpr.12816.


Prolyl Isomerase Pin1 in Human Cancer: Function, Mechanism, and Significance.

Pu W, Zheng Y, Peng Y Front Cell Dev Biol. 2020; 8:168.

PMID: 32296699 PMC: 7136398. DOI: 10.3389/fcell.2020.00168.